ACCESS REALMONEY
Email This Article
Headlines & Perspectives
FDA Approval Delay Sinks Discovery Labs
By
Elizabeth Trotta
05/02/08 - 08:22 AM EDT
Surfaxin receives an approvable letter, but the additional delays that accompany it send shares plummeting in premarket trading.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
